Treatment of Experimental Brain Tumors with Trombospondin-1 Derived Peptides: an In Vivo Imaging Study
Antiangiogenic and antiproliferative effects of synthetic D-reverse peptides derived from the type 1 repeats of thrombospondin (TSP1) [1,2] were studied in rodent C6 glioma and 9L gliosarcomas. To directly measure tumor size and vascular parameters, we employed in vivo magnetic resonance (MR) imagi...
Main Authors: | A. Bogdanov, Jr., E. Marecos, H.C. Cheng, L. Chandrasekaran, H.C. Krutzsch, D.D. Roberts, R. Weissleder |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1999-11-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558699800153 |
Similar Items
-
Identification of Trombospondin-1 as a Novel Amelogenin Interactor by Functional Proteomics
by: Angela Capolupo, et al.
Published: (2017-10-01) -
The use of Thrombospondin-1 Mimetic Peptides for the Treatment of Epithelial Ovarian Cancer
by: Campbell, Nicole
Published: (2012) -
IMMUNOREGULATORY PROPERTIES OF THROMBOSPONDIN-1, A EXTRACELLULAR MATRIX COMPONENT AND ANGIOGENESIS INHIBITOR
by: S. A. Kuznetsova, et al.
Published: (2014-07-01) -
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action
by: Marco Rusnati, et al.
Published: (2010-04-01) -
Cloning of the functional domains of TSP-1 for protein expression
by: Zangi, Shadi
Published: (2009)